Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation01:37

Neural Regulation

43.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Dynamic Affect Recognition Test: Construction and Validation in Neurodegenerative Syndromes.

Assessment·2026
Same author

TAF15 amyloids propagate via defined motifs in a prion-like fashion.

Nature communications·2026
Same author

Regional mapping of CSF1R-positive microglia in neurodegenerative diseases and progressive MS, with exploratory presynaptic marker analyses.

Journal of neuroinflammation·2026
Same author

Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple Cohorts.

bioRxiv : the preprint server for biology·2026
Same author

FTLD-TDP versus LATE-NC: Experience of a Brain Bank specializing in FTLD-TDP.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal Dementia.

JAMA neurology·2026

Related Experiment Video

Updated: Mar 6, 2026

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

987

Mapping Neurodegenerative Disease Onset and Progression.

William W Seeley1

  • 1Memory and Aging Center, Departments of Neurology and Pathology, University of California, San Francisco, California 94143.

Cold Spring Harbor Perspectives in Biology
|March 15, 2017
PubMed
Summary

Researchers are improving brain network mapping for neurodegenerative diseases. New in vivo neuroimaging complements traditional methods, offering insights into disease spread and guiding future research directions.

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.7K

Related Experiment Videos

Last Updated: Mar 6, 2026

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

987
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.7K

Area of Science:

  • Neuroscience
  • Neuropathology
  • Medical Imaging

Background:

  • Brain networks are crucial for understanding neurodegenerative diseases like prion diseases, which spread via neural pathways.
  • Traditional neuropathological studies, while informative, have limitations in studying in vivo, physiological, and longitudinal aspects of disease progression.
  • Existing tools for human brain network mapping have been inadequate for clinical research applications.

Purpose of the Study:

  • To address the limitations of traditional methods in mapping human brain networks in neurodegenerative diseases.
  • To explore the potential of emerging in vivo neuroimaging strategies for understanding disease anatomy and pathogenesis.
  • To provide a roadmap for future research by highlighting key principles and unanswered questions in neurodegeneration.

Main Methods:

  • Review and synthesis of findings from neuropathological studies.
  • Integration of emerging in vivo network-based neuroimaging strategies.
  • Analysis of data complementing traditional autopsy-based approaches.

Main Results:

  • In vivo neuroimaging offers complementary data to neuropathological studies.
  • Emerging strategies are beginning to address limitations in understanding human brain network architecture.
  • Current findings reveal fundamental principles and persistent mysteries in neurodegenerative disease pathogenesis.

Conclusions:

  • Network-based neuroimaging is crucial for advancing the study of neurodegenerative diseases.
  • The integration of in vivo and postmortem data provides a more comprehensive understanding.
  • Further research is needed to unravel the complexities of brain network involvement in neurodegeneration.